Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrii Dudnyk

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2018
Mission impossible: the End TB strategyAndrii Dudnyk, Dumitru Chesov, Christoph Lange
Respirology (Carlton, Vic.)|April 28, 2018
M/XDR-TB treatment perspective: How to avoid mountains of pills via digital technologiesAndrii Dudnyk, Matthew Burman, Ludmyla Kulyk, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
Multidrug-resistant tuberculosis in Ukraine at a time of military conflictAndrii Dudnyk, Olena Rzhepishevska, Kostiantyn Rogach, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
MDR-TB in Eastern Europe in the era of the TB elimination action frameworkAndrii Dudnyk, Dmytro Butov, Valeriu Crudu, et al.
Breathe (Sheffield, England)|March 19, 2025
The importance of getting the dose right in the treatment of tuberculosisAndrii Dudnyk, Wandini Lutchmun, Raquel Duarte, et al.
The Indian Journal of Tuberculosis|January 16, 2018
Initial airflow obstruction in new cases of pulmonary tuberculosis: Complication, comorbidity or missed?Andrii Dudnyk, Svitlana Blyzniuk, Oleksandr Pavel'chuk, et al.
Therapeutic Advances in Infectious Disease|April 24, 2026
A new multiplex molecular assay based on padlock probes and rolling circle amplification for MDR-TB detection in clinical specimens: a prospective diagnostic accuracy studyAndrii Dudnyk, Nadiia Tytarenko, Oksana Lytvyniuk, et al.
Therapeutic Advances in Respiratory Disease|May 31, 2024
Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in UkraineAndrii Dudnyk, Matthias Hempel, Oksana Lytvyniuk, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 6, 2026
Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy studyAndrii Dudnyk, Nadiia Tytarenko, Iris Romero Andrada, et al.
BMC Pregnancy and Childbirth|October 13, 2016
Pregnancy in patients with tuberculosis: a TBNET cross-sectional surveyGraham H Bothamley, Cordula Ehlers, Irina Salonka, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2018
Mission impossible: the End TB strategyAndrii Dudnyk, Dumitru Chesov, Christoph Lange
Respirology (Carlton, Vic.)|April 28, 2018
M/XDR-TB treatment perspective: How to avoid mountains of pills via digital technologiesAndrii Dudnyk, Matthew Burman, Ludmyla Kulyk, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 11, 2015
Multidrug-resistant tuberculosis in Ukraine at a time of military conflictAndrii Dudnyk, Olena Rzhepishevska, Kostiantyn Rogach, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
MDR-TB in Eastern Europe in the era of the TB elimination action frameworkAndrii Dudnyk, Dmytro Butov, Valeriu Crudu, et al.
Breathe (Sheffield, England)|March 19, 2025
The importance of getting the dose right in the treatment of tuberculosisAndrii Dudnyk, Wandini Lutchmun, Raquel Duarte, et al.
The Indian Journal of Tuberculosis|January 16, 2018
Initial airflow obstruction in new cases of pulmonary tuberculosis: Complication, comorbidity or missed?Andrii Dudnyk, Svitlana Blyzniuk, Oleksandr Pavel'chuk, et al.
Therapeutic Advances in Infectious Disease|April 24, 2026
A new multiplex molecular assay based on padlock probes and rolling circle amplification for MDR-TB detection in clinical specimens: a prospective diagnostic accuracy studyAndrii Dudnyk, Nadiia Tytarenko, Oksana Lytvyniuk, et al.
Therapeutic Advances in Respiratory Disease|May 31, 2024
Impact of line probe assay-based molecular testing on individualized treatment in patients with rifampicin-resistant tuberculosis: data from the prospective INNOVA4TB cohort study in UkraineAndrii Dudnyk, Matthias Hempel, Oksana Lytvyniuk, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 6, 2026
Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy studyAndrii Dudnyk, Nadiia Tytarenko, Iris Romero Andrada, et al.
BMC Pregnancy and Childbirth|October 13, 2016
Pregnancy in patients with tuberculosis: a TBNET cross-sectional surveyGraham H Bothamley, Cordula Ehlers, Irina Salonka, et al.
Pageof 2